United States Securities and Exchange Commission · EDGAR Accession 0001254348-25-000003

Form C

Offering Statement — Regulation Crowdfunding
Issuer CIK 1254348
Raising via Wefunder Portal LLC

EMulate Therapeutics, Inc.

CorporationWAIncorporated 2002Bellevue, WAemulatetx.com
A

The Offering

as disclosed in this filing
Common Stock
$10.54
$50,000
$1,235,000
April 30, 2026
Expired 45 days ago
$0max $1,235,000

Target is 4% of the maximum. Over-subscriptions accepted.

B

Financial Condition

two fiscal years, as filed
Pre-revenueBurn decreasingDebt / assets 3072%3 employees
Line itemMost recent FYPrior FYΔ
Revenue064,000▼ 100%
Cost of goods sold00
Net income(19,139,000)(22,926,000)▲ burn
Total assets1,193,0002,012,000▼ 41%
Cash & equivalents54,000240,000▼ 78%
Accounts receivable285,000300,000▼ 5%
Short-term debt30,988,00028,225,000▲ 10%
Long-term debt5,655,0005,676,000▼ 0%
Taxes paid00

Figures in USD as reported by the issuer. Securities offered in all 50 states.